Serological markers of autoimmunity in pregnant women with polycystic ovary syndrome: A pilot study

Gynecological Endocrinology

Volumn 26, Issue 12, 2010, Pages 889-893

  Pérez Bravo, Francisco ^a   Carrasco, Elena ^b   Echibur, Bárbaraú ^a   Maliqueo, Manuel ^a   Diaz, Jaime ^b   Sir Petermann, Teresa ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Diabetes; insulin resistance; polycystic ovary syndrome

Indexed keywords

AUTOANTIBODY; GLUCOSE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IA2 ANTIBODY; INSULIN; LIPID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; SEROLOGY;

AUTOANTIBODIES; AUTOIMMUNITY; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREVALENCE; TRIGLYCERIDES;

EID: 78149431222     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.487616     Document Type: Article

References (35)

1. Franks S. Polycystic ovary syndrome. New Engl J Med 1995;333:853-861.
2. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438. (Pubitemid 32269197)
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749. (Pubitemid 38766360)
4. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002;26:883-896. (Pubitemid 34756169)
5. Norman RJ, Noakes M, Wu R, Davies MJ, Moran L, Wang JX. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 2004;10:267-280. (Pubitemid 38744871)
6. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Bailliere Clin Endocrinol Metab 1996;10:221-247. (Pubitemid 26166053)
7. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. EndocrRev 1997;18:774-800. (Pubitemid 28009567)
8. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146. (Pubitemid 29028311)
9. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Pre-valence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-169. (Pubitemid 29036695)
10. Banaszewska B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Lipids in polycystic ovary syndrome: role of hyperinsulinemia and effects of metformin. Am J Obstet Gynecol 2006;94: 1266-1272.
11. Cenk Sayin N, Gücer F, Balkanli-Kaplan P, Ali Yüce M, Yardim T. Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome. Gynecol Endocrinol 2003;17: 387-396. (Pubitemid 37338869)
12. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006;20:281-292. (Pubitemid 43842931)
13. Konstantinos AT, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I. Risk ofgestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril 2009;92: 667-677.
14. Metzger BE. CDR: proceedings of the fourth international workshop conference on gestational diabetes mellitus. Dia-betes Care 1998;21: B1-B167.
15. Johnston DG, Beard RW, Chan SP, Dornhorst A, Elkeles RS, Gelding SV, Nicholls JS, Robinson S. Aspects ofmetabolism in normal and gestational diabetes pregnancy. Biochem Soc Trans 1995;23:512-516.
16. De Leiva A, Didac M, Corcoy R. Diabetes-related auto-antibodies and gestational diabetes. Diabetes Care 2007;30: S127-S133.
17. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamäki K, Stenga°rd J, Rowley MJ. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset ofdisease. Lancet 1994;43:1383-1385. (Pubitemid 24167509)
18. Dozio N, Beretta A, Belloni C, Castiglioni M, Rosa S, Bosi E, Bonifacio E. Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus. Diabetes Care 1997;20:81-83. (Pubitemid 27020047)
19. Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, de Leiva A, Corcoy R. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 2003;26: 1199-1205. (Pubitemid 36929272)
20. Järvelä IY, Juutinen J, Koskela P, Hartikainen AL, Kulmala P, Knip M, Tapanainen JS. Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care 2006;29:607-612. (Pubitemid 44115362)
21. Sir-Petermann T, Echiburú B, Maliqueo MM, Crisosto N, Sánchez F, Hitschfeld C, Cárcamo M, Amigo P, Pérez-Bravo F. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 2007; 22:1830-1836. (Pubitemid 47062748)
22. ZawadzkyJK, Dunaif A. Diagnosis criteria: towards a rational approach. In: Hershmann JM, editor. Current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publications; 1992. pp 377-384.
23. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47. (Pubitemid 38072004)
24. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-359 (Pubitemid 16034121)
25. Report of a WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: Department of Non-communicable Disease Surveil-lance; 1999.
26. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003;52:1128-1136. (Pubitemid 36523346)
27. Hollander MH, Paarlberg KM, Huisjes AJ. Gestational diabetes: a review of the current literature and guidelines. Obstet Gynecol Surv 2007;62:125-136. (Pubitemid 46146816)
28. Murgia C, Berria R, Minerba L, Sulis S, Murenu M, Portoghese E, Garau N, Zedda P, Melis GB. Risk assessment does not explain high prevalence of gestational diabetes mellitus in a large group of Sardinian women. Rep Biol and Endocrinol 2008;6:26. (Pubitemid 352025071)
29. Mitchell ML, Hermos RJ, Larson CA, Palomaki GE, Haddow JE. Prevalence of GAD autoantibodies in women with gestational diabetes. Diabetes Care 2000;23:1705-1706.
30. Nilsson CN, Ursing D, Torn C, Aberg A, Landin-Olsson M. Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes. Diabetes Care 2007;30: 1968-1971. (Pubitemid 47219402)
31. Ferraz TB, Motta RS, Capibaribe DM, Ferraz CL, Chacra AR, Forti AC, Dib SA. Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes. Diab Res Clin Pract 2007;78:141-142. (Pubitemid 47354219)
32. Kousta E, Lawrence NJ, Anyauku V, Johnston DG, McCarthy MI. Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groups. Br J Obstet Gynecol 2001;108:716-720. (Pubitemid 32778278)
33. Lee SH, Kim MR, Kim JH, Kwon HS, Yoon KH, Son HY, Cha BY. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2. Gynecol Endocrinol 2007;23:252-256. (Pubitemid 46897701)
34. Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C, Hefler L. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril 2009; 92:e59.
35. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009;43:157-168.